- NanoString press release ( NASDAQ: NSTG ): Q3 GAAP EPS of -$0.79.
- Product and Services Revenue of $29.54M (-20.5% Y/Y).
- nCounter® revenue, inclusive of all service revenue, of $20.2 million.
- During the quarter, the company generated orders for ~60 Spatial Biology Instruments, representing ~70% growth year-over-year, including orders for ~40 CosMx Spatial Molecular Imagers
- FY 2022 Outlook: Total product and service revenue of $125 to $127 million, as compared to previous guidance of $140 to $150 million, reflecting an order mix that is weighted more heavily to CosMx, with material CosMx revenue recognition expected to begin in 2023
- nCounter revenue, inclusive of all service revenue, of $83 to $84 million, as compared to previous guidance of $90 to $95 million
- Adjusted EBITDA loss of approximately $100 million, as compared to previous guidance of $75 to $85 million
For further details see:
NanoString GAAP EPS of -$0.79, revenue of $29.54M